Dendritic cells (DCs) are important accessory cells for promoting NK cell gamma interferon (IFN-␥) production in vitro in response to
Studies performed with humans and with mice indicate that NK cells are a crucial and early source of gamma interferon (IFN-␥) during blood-stage malaria infection (3, 4, 12, 28) . Consistent with findings with other infectious agents, tumors, and inflammatory diseases, optimal NK cell IFN-␥ production during malaria requires accessory cells (10, 11) . Newman et al. (29) demonstrated that IFN-␥ production by human NK cells in response to Plasmodium falciparum-infected red blood cells (iRBC) occurs only following multiple contact-dependent and cytokine-mediated signals derived from myeloid dendritic cells (DCs) and monocytes. The proinflammatory cytokines type 1 IFN, interleukin 2 (IL-2), IL-12, and to a lesser extent IL-18, but not IL-15, were found to be required for NK cell activation, while transforming growth factor ␤ suppressed NK cell activation (3, 4, 29) . Reciprocal regulation of accessory cell maturation by NK cells was observed to be similar to findings of bidirectional interactions between NK cells and accessory cells in other systems (10, 11, 16, 17) . On the other hand, Baratin et al. (6) reported that human monocytes, not DCs, are required to induce NK cell IFN-␥ production in vitro in response to P. falciparum iRBC. That study also implicated multiple accessory cell-derived signals, including IL-12 and IL-18, as requirements for NK cell IFN-␥ production in response to iRBC, and an IL-18R/MyD88-dependent pathway was demonstrated to be necessary for NK cell activation (6) . Together, these studies indicate that NK cell activation following exposure to iRBC in vitro requires an accessory cell, but the identity of this cell is unclear, as is the relevance of interactions between NK cells and accessory cells to the in vivo control of blood-stage malaria.
Given the importance of the innate immune response in shaping adaptive immunity, a better understanding of the cellular mechanisms and cytokines involved in cross talk between NK cells and accessory cells during malaria is required. Control and resolution of Plasmodium chabaudi AS infection in mice critically requires IL-12-dependent IFN-␥ production by NK cells and CD4 ϩ T cells (37) . During acute P. chabaudi AS infection in resistant C57BL/6 (B6) mice, NK cells, macrophages, and DCs rapidly accumulate and expand in the spleen, where they undergo maturation and functional activation in response to iRBC captured in the spleen for removal (24, 25, 28, 32, 46) . Notably, CD11c
ϩ DCs migrate from the marginal zone to the CD4 ϩ T-cell-rich periarteriolar lymphoid sheaths during early infection, while macrophages expand and remain in the red pulp (25) . Contrary to reports of functional impairment of DCs during lethal infections due to Plasmodium berghei, P. yoelii YM, or P. vinckei, the in vitro or in vivo exposure of bone marrow-derived or splenic DCs to P. chabaudi AS iRBC results in upregulation of major histocompatibility complex class II and costimulatory molecule expression; production of the proinflammatory cytokines IL-12, IFN-␥, tumor necrosis factor alpha (TNF-␣), and IL-6; and the ability to stimulate naïve CD4 ϩ T-cell proliferation and IFN-␥ production (23-25, 34, 45, 46) . In contrast, splenic macrophages from P. chabaudi AS-infected mice suppress T-cell proliferation and IL-2 production (1, 33) . Similar findings concerning the ability of DCs to activate T cells as opposed to macrophage-mediated suppression of T-cell activation were reported in mice with a nonlethal P. yoelii infection (26, 30) . Together, these findings provide compelling evidence that DCs play an important role in innate immunity during blood-stage malaria and shape an adaptive type 1 immune response necessary for control and rapid resolution of infection.
In the present study, we investigated the requirements for reciprocal activation of DCs and NK cells leading to priming of CD4 ϩ Th1 cell responses in P. chabaudi AS-infected mice using in vitro and in vivo approaches. DC maturation, cytokine production, and the ability to activate NK cell IFN-␥ production in vitro were compared among wild-type (WT) B6, IL-15 Ϫ/Ϫ , and IL-12p40 Ϫ/Ϫ mice that differed in the severity of infection with the parasite (23, 40) . The in vivo contribution of DC-NK cell cross talk to the development of immunity to malaria was determined in NK cell-depleted WT mice, which are unable to control blood parasitemia as efficiently as intact mice (28) . Our findings confirm and extend previous observations concerning DC-NK cell interactions in vitro and provide novel evidence for the in vivo relevance of DC and NK cell cross talk during the innate immune response to blood-stage malaria leading to the induction of adaptive type 1 immunity.
MATERIALS AND METHODS

Mice and parasite. IL-12p40
Ϫ/Ϫ , IL-15 Ϫ/Ϫ , and IFN-␥ Ϫ/Ϫ mice on the B6 background, obtained as previously described (23, 39, 40) , were bred and maintained at the Research Institute of the McGill University Health Centre (Montreal, QC, Canada). Age-matched B6 mice (Charles River Laboratories, St. Constant, QC, Canada) were used as WT controls. Female mice, aged 8 to 14 weeks, were used in all experiments. Experiments were conducted in accordance with the guidelines of the Canadian Council on Animal Care. P. chabaudi AS was maintained as previously described (38) , and infections were initiated by intraperitoneal injection of 10 6 iRBC.
Purification of CD11c
؉ , DX5 ؉ , and CD4 ؉ cells from spleen. Spleens were harvested from naïve and infected mice at the indicated times and perfused with a sterile solution of 1% fetal calf serum (HyClone Laboratories, Logan, UT) in phosphate-buffered saline (PBS), teased apart, and pressed gently through a sterile fine wire mesh. The RBC were removed by incubation with NH 4 Cl lysing buffer. To obtain DCs, splenocytes were suspended in sterile PBS containing 5 mM EDTA (Sigma-Aldrich Co., St. Louis, MO) and separated using a Nycoprep 1.077A (Axis-Shield, Oslo, Norway) density gradient. Low-density cells at the interphase were collected and further purified by positive selection using antiCD11c microbeads (Miltenyi Biotec, Auburn, CA) according to the manufacturer's instructions. The purity of CD11c ϩ cells was confirmed by flow cytometry for each experiment and was routinely 88 to 90% CD11c ϩ ; 4 to 8% also expressed DX5. NK cells and CD4 ϩ T cells were also enriched from spleen cells using anti-DX5 and anti-CD4 microbeads (Miltenyi Biotec), respectively. NK cells were 85 to 90% positive for DX5; 3 to 9% also expressed CD11c, and 25% expressed CD3. The purity of CD4 ϩ T cells was routinely Ն90%. Analysis of DC uptake of iRBC by flow cytometry. DC uptake of iRBC was determined as previously described (24) . Briefly, purified iRBC and normal RBC (nRBC) were obtained from P. chabaudi-infected or naïve B6 mice, respectively, as described previously (24) . Purified iRBC (Ͼ96% iRBC) or nRBC were resuspended at 10 7 per ml in RPMI 1640 (Gibco-Invitrogen, Burlington, ON, Canada) containing 5% fetal calf serum (HyClone), 10 mM HEPES (GibcoInvitrogen), 20 g/ml gentamicin (Sabex Inc., QC, Canada), 2 mM L-glutamine (Gibco-Invitrogen), and 0.5 M ␤-mercaptoethanol (Sigma-Aldrich Co.) and stained with 2 M carboxyfluorescein succinimidyl ester (CFSE) (Molecular Probes, Eugene, OR) for 15 min at 37°C. Splenic CD11c ϩ DCs (10 6 /well) were plated with CFSE-labeled iRBC or nRBC at a 1:20 ratio in a final volume of 200 l of complete RPMI 1640 medium and incubated at 37°C for 4 h. Noningested iRBC or nRBC were lysed, and the DCs were washed, treated with anti-CD16/ ϩ cells expressing the above-mentioned markers were determined by flow cytometry. For analysis of cytokine production, CD11c
ϩ DCs (10 6 /well) were plated and incubated in medium alone or with iRBC (1:10 ratio) for 48 h at 37°C. Cytokine levels were determined in supernatants by enzyme-linked immunosorbent assay (ELISA) as previously described (38, 39) . To determine the ability of DCs to stimulate CD4 ϩ T cells, 5 ϫ 10 5 DCs in 100 l were plated with splenic CD4 ϩ T cells, freshly purified from naïve B6 mice, in 96-well flat-bottom plates (Nalge Nunc International, Naperville, IL) at the indicated ratios in a final volume of 200 l for 48 h at 37°C. Proliferation was determined by incorporation of [ 3 H]thymidine added during the last 16 h of incubation. Supernatants of DC and T-cell cocultures were collected and analyzed for cytokine production by ELISA as described previously (38, 39) .
DC-NK cell cocultures. To determine if malaria-activated DCs promoted NK cell IFN-␥ production, CD11c
ϩ DCs were purified from the spleens of day 5 infected WT or cytokine-deficient mice and cocultured with NK cells purified from naïve WT mice or, in some experiments, from IFN-␥ Ϫ/Ϫ mice. For cocultures, DCs (10 6 /well) were plated together with NK cells (10 6 /well) in 96-well flat-bottom plates for 24 to 36 h at 37°C. In some experiments, NK cells were cultured in the lower well and DCs were added separately in the upper compartment of a 96-well plate fitted with transwell inserts (Nalge Nunc International). Single cultures of DCs and NK cells were always included as controls. In some experiments, DCs were pretreated with 250 ng/ml anti-IL-2 MAb (clone JES6-1A12; R&D Systems) or isotype control immunoglobulin G (IgG) for 4 h prior to coculture with NK cells.
To determine the effects of malaria-activated NK cells on resting DCs, purified DX5 ϩ NK cells from day 5 infected WT or IFN-␥ Ϫ/Ϫ mice were cocultured at a 1:1 ratio with CD11c ϩ DCs from naïve WT mice preactivated with iRBC for 1 h prior to coculture to prevent DC lysis by activated NK cells. DCs (1 ϫ 10 6 ) were plated with NK cells (1 ϫ 10 6 ) in 96-well flat-bottom plates for 18 to 24 h at 37°C. Costimulatory molecule expression was determined on gated CD11c ϩ DX5 Ϫ cells as described above, and supernatants were collected and analyzed for cytokine levels by ELISA. The ability of DCs cocultured with activated NK cells to prime naïve CD4 ϩ T cells was assessed using a modification of a protocol described by Mailliard et al. (27) . Briefly, DCs (2 ϫ 10 5 ) and NK cells (2 ϫ 10 5 ) were cocultured in 48-well plates at 37°C; 18 to 24 h later, splenic CD4 ϩ T cells (2 ϫ 10 6 ), freshly purified from naïve mice, were added. For CFSE dilution assays, CD4 ϩ T cells were stained with 5 mM CFSE (Molecular Probes) prior to addition to DC-NK cell cocultures. After 2 days, fresh medium containing recombinant IL-2 (10 ng/ml; R&D Systems) was added and the plates were further incubated for 72 h at 37°C. Cells were collected and adjusted to 5 ϫ 10 5 /ml, and 200 l was plated for 48 h at 37°C in 96-well flat-bottom plates coated with 5 g/ml anti-CD3ε MAb (clone 145-2C11; BD Biosciences). Proliferation was determined by CFSE dilution in gated ϩ T cells, cells were stimulated as described above for 5 h and then stained with FITC-conjugated anti-CD4 MAb (clone GK1.5; BD Biosciences), fixed and permeabilized, and stained with APC-conjugated anti-IFN-␥, APC-conjugated anti-IL-10 (clone JES5-2A5; eBioscience), or PEconjugated anti-IL-4 (clone 11B11; eBioscience) MAb.
In vivo NK cell depletion. WT mice were depleted of NK cells by intravenous injection with 80 g anti-asialo-GM1 antibody (Wako Chemicals, Richmond, VA) on days Ϫ7, Ϫ4, 0, and 2 postinfection (p.i.). This treatment resulted in Ͼ90% depletion of DX5 ϩ NK cells in the spleen, as confirmed by flow cytometry (28) . Control mice were treated similarly with normal rabbit IgG as an isotype control antibody or with sterile PBS. To assess DC maturation and function after NK cell depletion, splenic CD11c ϩ cells were purified as described above and analyzed for costimulatory molecule expression, cytokine production, and the ability to prime CD4 ϩ T cells. Statistical analyses. Data are expressed as means Ϯ standard errors of the mean (SEM). The statistical significance of differences between two groups was analyzed by Student's t test, and multiple comparisons were analyzed using analysis of variance. All statistical analyses were performed using SAS/ STAT software (SAS Institute, Cary, NC).
RESULTS
IL-12, but not IL-15
, is required for optimal DC maturation during blood-stage malaria. We first compared the uptake of iRBC and costimulatory molecule expression by CD11c ϩ DCs purified from the spleens of naïve and infected WT, IL-15 Ϫ/Ϫ , and IL-12p40 Ϫ/Ϫ mice. As we previously reported (24), WT DCs from both naïve and infected mice captured iRBC at significantly higher levels than nRBC, and the uptake of iRBC was selectively enhanced to peak levels within 4 to 5 days of infection and declined thereafter (Fig. 1A and B) . DCs from IL-15 Ϫ/Ϫ and IL-12p40 Ϫ/Ϫ mice captured iRBC in vitro as efficiently as WT DCs both before and after infection (Fig. 1B) . On day 4 p.i., similar increases in CD40, CD80, and CD86 expression were observed in DCs from WT and IL-15 Ϫ/Ϫ mice, but IL-12p40 Ϫ/Ϫ DCs had significantly lower costimulatory molecule expression than WT DCs (Fig. 1C) . These findings indicate that in the absence of IL-15 or IL-12p40, recognition mice. In agreement with previous findings (23, 25, 34) , DCs recovered from P. chabaudi AS-infected WT mice produced normal or even higher levels of IL-12p70, IFN-␥, IL-2, and IL-10 than DCs from naïve WT mice following in vitro stimulation with either medium or iRBC (Fig. 2) . Similarly, infection did not inhibit the ability of DCs from IL-15 Ϫ/Ϫ or IL12p40 Ϫ/Ϫ mice to secrete cytokines. As shown in Fig. 2A , after infection, WT and IL-15 Ϫ/Ϫ DCs produced equivalent levels of IL-12p70 in vitro in response to medium or iRBC, but WT DCs produced significantly higher levels of IFN-␥ than IL-15
DCs, a finding confirmed by intracellular IFN-␥ expression (Fig. 2B) . No detectable IL-2 was produced by DCs from infected WT and IL-15 Ϫ/Ϫ mice in response to medium, and only low levels of the cytokine were produced in response to iRBC. DCs from infected IL-12p40 Ϫ/Ϫ mice also produced less IFN-␥ in response to medium or iRBC than infected WT DCs, as was apparent in the significantly lower levels of IFN-␥ in the culture supernatants and a lower frequency of CD11c ϩ cells expressing intracellular IFN-␥ ex vivo. After infection, IL12p40 Ϫ/Ϫ DCs secreted more IL-2 than WT DCs in response to medium or iRBC, a finding confirmed by a higher frequency of CD11c ϩ IL-2 ϩ cells ex vivo among DCs from infected IL12p40 Ϫ/Ϫ mice ( Fig. 2A and C ). Despite differences in type 1 cytokine production by DCs from infected WT, IL-15 Ϫ/Ϫ , and IL-12p40 Ϫ/Ϫ mice, IL-10 secretion was enhanced to similar levels following iRBC stimulation of DCs from WT or cytokine-deficient mice after P. chabaudi AS infection ( Fig. 2A) .
DCs from infected WT mice promote IFN-␥ production by NK cells. Next, we investigated if DCs from P. chabaudi ASinfected mice promoted IFN-␥ production by NK cells by coculturing splenic DCs purified from infected WT mice with resting NK cells purified from spleens of naïve WT mice. Because both DCs and NK cells produce IFN-␥ during P. chabaudi AS infection (24, 25) (Fig. 3A, pre-versus postculture) . Likewise, few DX5 ϩ CD3
Ϫ NK cells expressed intracellular IFN-␥ prior to coculture (Fig.  3B) . Notably, after coculture with DCs from infected WT mice, the frequency of DX5 ϩ CD3 Ϫ IFN-␥ ϩ NK cells increased markedly from 6.58% to 35.80% (Fig. 3B , pre-versus postculture). These findings indicate that DX5 ϩ CD3 Ϫ NK cells were the major source of IFN-␥ in the cocultures, a result corroborated when WT DCs from infected mice were cocultured with resting NK cells from naïve IFN-␥ Ϫ/Ϫ mice (data not shown). Determination of IFN-␥ levels in coculture supernatants confirmed that WT DCs from infected mice stimulated higher IFN-␥ production than WT DCs from naïve mice (Fig. 3C) . DC-NK cell interaction was dependent on cell-cell contact, as demonstrated by the significantly lower IFN-␥ production in wells in which NK cells and DCs were separated by a transwell insert. Although it has been shown that DCs also elicit TNF-␣ secretion by NK cells (16, 31) , we observed only background levels of TNF-␣ in the supernatants of DC-NK cell cocultures (data not shown). Taken together, these results demonstrate that splenic DCs from malaria-infected WT mice promoted resting NK cells to produce high levels of IFN-␥.
IL-12 and IL-2, but not IL-15, are required for DC-mediated stimulation of NK cell IFN-␥ production. To determine the relative contributions of IL-15 and IL-12 to DC-NK cell interactions during blood-stage malaria, DCs from P. chabaudi ASinfected IL-15 Ϫ/Ϫ and IL-12p40 Ϫ/Ϫ mice were cocultured as described above with NK cells from naïve WT mice. As shown in Fig. 4A , DCs from infected IL-15 Ϫ/Ϫ mice stimulated a percentage of WT NK cells similar to that stimulated by WT DCs (32.7% versus 36.1%, respectively) to express intracellular IFN-␥. In contrast, DCs from infected IL-12p40 Ϫ/Ϫ mice were unable to promote IFN-␥ expression by resting WT NK cells (6.3%) (Fig. 4A, right) . IFN-␥ levels were similar in the supernatants of cocultures containing DCs from infected WT mice and those containing DCs from infected IL-15 Ϫ/Ϫ mice, while significantly less IFN-␥ was detected in the supernatants of cocultures with DCs from infected IL-12p40 Ϫ/Ϫ mice (Fig. 4B ). These findings indicate that DCs from infected IL-12p40 Ϫ/Ϫ mice had impaired maturation and type 1 cytokine production and were unable to promote NK cell IFN-␥ production.
In addition to IL-12 and IL-15, DC-derived IL-2 has been shown to be important for DC-NK cell cross talk (2, 14, 19) . We therefore asked if the ability of IL-15 Ϫ/Ϫ DCs to stimulate IFN-␥ production by NK cells was due to the compensatory effect of IL-2. The addition of neutralizing anti-IL-2 MAb significantly reduced IFN-␥ production in cocultures of IL-15 Ϫ/Ϫ DCs and WT NK cells, as well as in cocultures of WT DCs and WT NK cells (Fig. 4C ). This suggests that low levels of IL-2 production by WT and IL-15 Ϫ/Ϫ DCs from infected mice, as shown in Fig. 2A above, may partially account for the ability of malaria-activated IL-15 Ϫ/Ϫ DCs to promote IFN-␥ production by resting WT NK cells. Anti-IL-2 MAb also significantly reduced NK cell IFN-␥ production in cocultures of WT NK cells and infected IL-12p40 Ϫ/Ϫ DCs, suggesting that high IL-2 secretion by these DCs, as shown in Fig. 2 , did not compensate for the detrimental effects of IL-12 deficiency on DC-stimulated NK cell activation. Together, these data indicate that IL-12 and to a lesser extent IL-2, but not IL-15, produced by DCs during the innate immune response to bloodstage P. chabaudi AS were required to promote optimal IFN-␥ secretion by NK cells during malaria.
Malaria-activated NK cells enhance DC maturation, cytokine production, and the ability to activate CD4 ؉ Th1 cells. Previous studies indicated that NK cells activated by tumor antigens, bacterial products, or IL-2 induce DCs to mature and produce Th1-promoting IL-12 (15) (16) (17) 31) . Because splenic NK cells from WT mice have increased cytolytic activity and IFN-␥ production during P. chabaudi AS infection (28), we investigated if activated NK cells from infected WT mice were capable of enhancing DC function. In preliminary studies, we obtained a lower recovery rate of CD11c ϩ cells when DCs from (16, 31) . To circumvent this problem, DCs from naïve mice were incubated with iRBC for 1 h, followed by treatment with lysing buffer prior to coculture with NK cells. For the experiments shown here, cells were cultured at the optimal ratio of 1:1 for DC-NK cells. WT DCs cocultured with WT NK cells from infected mice showed higher upregulation of CD40 and CD86 expression than control DCs cultured alone or with NK cells from naïve WT mice (Fig. 5A ). DCs cocultured with WT NK cells in the presence of anti-IFN-␥ MAb or isotype control MAb (data not shown) or cocultured with IFN-␥ Ϫ/Ϫ NK cells exhibited phenotypic maturation similar to that of DCs cocultured with NK cells from infected WT mice (Fig. 5A) . Although the percentages of DCs expressing each maturation marker were comparable (data not shown), DCs cocultured with malaria-activated NK cells in transwells expressed significantly lower MFI levels of CD40 and CD86 (Fig. 5A ). These data suggest that DC-NK cell contact, and not soluble factors, supported optimal DC maturation by NK cells.
Malaria-activated NK cells also stimulated DCs to secrete higher levels of cytokine, especially IL-12, than those observed in DCs cultured alone (Fig. 5B) . The addition of anti-IFN-␥ MAb resulted in significantly decreased IL12p40 and IL-12p70, but increased IL-10, levels in cocultures of DCs and malaria-activated WT NK cells (Fig. 5B) compared to the addition of isotype control MAb (data not shown). Similar results were obtained with WT DCs cocultured with NK cells from P. chabaudi AS-infected IFN-␥ Ϫ/Ϫ mice, demonstrating that NK cell-derived IFN-␥ is required for enhanced IL-12 production by DCs during malaria. While some NK cell subsets are capable of producing IL-10 after infection, in our hands, only background levels were detected in day 5 NK cells cultured alone (data not shown). DCs cultured in wells separated from NK cells by a transwell insert showed levels of cytokine production similar to those in cocultures, suggesting that soluble factors released from NK cells, and not cell-cell contact, were responsible for cytokine production by DCs. Thus, cell-cell contact was required for optimal DC phenotypic maturation, while stimulation of high IL-12 production by malaria-activated NK cells was dependent on soluble mediators, particularly IFN-␥. The ability of DCs stimulated by malaria-activated NK cells to prime CD4 ϩ Th1 cell responses was also examined. In the absence of CD4 ϩ T cells, control cultures of anti-CD3-stimulated DCs or NK cells alone or cocultures of DCs and NK cells did not proliferate or produce cytokines above background levels (data not shown). Similarly, proliferation and cytokine secretion were low in CD4 ϩ T cells cultured with either DCs or NK cells alone (Fig. 6) . In contrast, CD4
ϩ T cells cultured with NK cell-activated DCs proliferated vigorously, as assessed by both [ 3 H]thymidine incorporation (Fig. 6A ) and CFSE staining of gated CD4 ϩ T cells (Fig. 6B) . Significantly higher levels of the type 1 cytokine IFN-␥ were secreted in the supernatants of CD4 ϩ T cells cultured with NK cell-activated DCs than in that of T cells cultured in medium or with either DCs or NK cells alone (Fig. 6C) . This finding was reflected in the higher percentage of CD4 ϩ T cells expressing intracellular IFN-␥ in cultures with NK cell-activated DCs (Fig. 6D) . Consistent with the results presented in Fig. 5 , DCs activated by NK cells from infected WT mice stimulated significantly higher levels of CD4 ϩ T-cell proliferation than did DCs activated by infected IFN-␥ Ϫ/Ϫ NK cells (Fig. 6A and B ). DCs cultured with infected IFN-␥ Ϫ/Ϫ NK cells stimulated CD4 ϩ T cells to produce significantly lower levels of IFN-␥ but higher levels of IL-4, as well as IL-10, than DCs activated by NK cells from infected WT mice ( Fig. 6C and D) . Thus, NK cells from P. chabaudi ASinfected WT mice stimulated DCs to activate CD4 ϩ Th1 cells via an IFN-␥-dependent mechanism. 
Depletion of NK cells results in higher parasitemia and impairs splenic CD11c
؉ DC maturation. To determine whether NK cells are required for optimal DC activation in vivo, WT mice were treated with anti-asialo-GM1 antibody (Ab) and infected with P. chabaudi AS. As we previously observed (28), depletion of NK cells in WT mice led to higher peak parasitemia and a higher recrudescence later during the infection than with control mice treated with isotype control rabbit IgG or with PBS-treated mice (Fig. 7A) . No mortality was observed among the three groups of infected animals (data not shown). CD11c ϩ DCs purified from the spleens of NK cell-depleted infected mice expressed lower levels of costimulatory molecules (CD40 and CD86) than DCs from isotype control Ab-treated mice (Fig. 7B) . This observation suggests that DC maturation was deficient in the absence of NK cells during blood-stage malaria. In addition, DCs from NK celldepleted mice produced significantly less IL-12p40 and IL12p70 but more IL-2 in response to iRBC in vitro than isotype control Ab-treated mice (Fig. 7C) . Soluble IL-15 was not detected in the DC cultures (data not shown). Importantly, impairment of DC maturation and IL-12 production in NK celldepleted mice resulted in significantly lower CD4 ϩ T-cell proliferation (Fig. 7D ) and IFN-␥ production (Fig. 7E ) than with DCs from isotype control Ab-treated mice. These data provide important evidence that NK cells are required in vivo for optimal DC maturation, as well as IL-12-dependent stimulation of Th1 cell development, leading to high IFN-␥ production and efficient immune control of blood-stage malaria infection.
DISCUSSION
Here, we investigated the interactions between NK cells and DCs as accessory cells in the mouse model of P. chabaudi AS infection. Determination of DC maturation and function in P. chabaudi AS-infected WT B6 mice revealed that, within 4 to 5 days p.i., splenic CD11c ϩ DCs captured iRBC, expressed high levels of costimulatory molecules, and produced important proinflammatory and immunoregulatory cytokines, especially the type 1-promoting cytokine IL-12. These findings are in agreement with previous studies of DC function during early infection with this Plasmodium species, which causes a nonlethal infection in WT B6 mice (23, 25, 46 (45, 46) .
The exposure of DCs to iRBC may lead to expansion of DC subsets that differ in their abilities to induce effector CD4 ϩ T cells (21, 36, 44) . Depending on their functional maturation or subset affiliation, DCs may also promote regulatory T-cell differentiation (22) . Differences in T-cell priming may be due to underlying differences in cytokine production by DCs from Plasmodium-infected mice. During early P. chabaudi AS infection, DCs from IL-15 Ϫ/Ϫ mice produced levels of IL-12p70 equivalent to those produced by DCs from WT mice in response to stimulation in vitro with iRBC. In contrast to the observation of impaired IL-2 production by bone marrowderived DCs from IL-15 Ϫ/Ϫ mice in response to Toll-like receptor-dependent stimuli (13) , DCs from infected WT and IL-15 Ϫ/Ϫ mice stimulated with iRBC produced equivalent levels of IL-2 in vitro. Although there were no differences among the mouse strains in DC production of IL-10, DCs from infected IL-15-and IL-12p40-deficient mice produced significantly less IFN-␥ than WT DCs in response to iRBC.
Of note, DCs from infected IL-12p40-deficient mice produced high levels of IL-2. To our knowledge, the ability of DCs from P. chabaudi AS-infected IL-12p40 Ϫ/Ϫ mice to produce high levels of IL-2 has not been reported previously. IL-2 is produced by DCs in response to stimulation with Toll-like receptor ligands and acts as a key molecule regulating NK cell IFN-␥ production following bacterial challenge (18, 19) . In addition, IL-2, together with transforming growth factor ␤, plays a role in the maintenance and activation of CD4 ϩ CD25 ϩ Foxp3 ϩ regulatory T cells, which have been implicated in suppressing immunity to malaria (9, 20, 35, 42, 43) . In our hands, blocking DC-derived IL-2 in cocultures of DCs from infected mice and NK cells from naïve mice significantly reduced NK cell IFN-␥ production, but the impact of neutralizing DCderived IL-2 on subsequent CD4 ϩ T-cell activation is unclear. In addition to their ability to mature phenotypically and to produce Th1-promoting cytokines in vitro during early P. chabaudi AS infection, splenic CD11c ϩ DC from infected WT mice promoted high IFN-␥ production by resting NK cells from naïve WT mice via a mechanism dependent in part on ϩ DCs from naïve mice (Day 0 DC) or from day 5 infected mice treated with control IgG or anti-asialo-GM1 Ab were cocultured with CD4 ϩ T cells from naïve mice for 36 to 48 h, and the proliferation (D) and IFN-␥ production (E) were determined. As a control, CD4 ϩ T cells were cultured with iRBC alone (T cell). In panels A to E, the data are representative of two independent experiments, each with four mice per group. The asterisks indicate significant differences between DCs from control mice versus DCs from mice treated with anti-asialo-GM1Ab: * , P Ͻ 0.05; ** , P Ͻ 0.01; and *** , P Ͻ 0.001. The error bars indicate SEM. Ϫ/Ϫ mice promoted NK cell IFN-␥ secretion to an extent similar to that of WT DCs, supporting the observation in human peripheral blood mononuclear cells that IL-15 does not contribute to NK cell IFN-␥ production in response to P. falciparum iRBC (29) . Together, these findings indicate that DC-derived IL-12 is the major cytokine regulating NK cell IFN-␥ production during malaria.
Our findings further revealed that NK cells from infected WT mice, in turn, stimulated DCs to mature and secrete cytokines, including IL-12. NK cell-activated DCs provided a link between innate and adaptive immunity, as evidenced by their ability to prime naïve CD4 ϩ T cells to proliferate and produce Th1-polarizing cytokines, indicating that these DCs were fully licensed antigen-presenting cells. The ability of malaria-activated NK cells to enhance the capacity of DCs to produce IL-12 and to promote IFN-␥-secreting CD4 ϩ T cells required both cell-cell contact and NK cell-derived IFN-␥. These findings are consistent with the demonstration that in vivo depletion of NK cells in WT mice results in increased parasite growth and delayed clearance. We observed that the inability of NK cell-depleted WT mice to efficiently control malaria was correlated with defects in DC maturation and function. In particular, DCs from NK cell-depleted WT mice showed a severely compromised ability to produce IL-12 and promote IFN-␥-producing CD4 ϩ T cells. In conclusion, our results provide in vitro and in vivo evidence for the importance of DC and NK cell cross talk during early blood-stage P. chabaudi AS infection. Together, our findings define the mechanisms involved in the reciprocal activation of these cell types leading to the induction of CD4 ϩ Th1-dependent protective immunity to malaria. These findings may help to identify relevant immunological targets for the development of an effective malaria vaccine and novel immunotherapy against the devastating worldwide menace of malaria.
